Back to Agendas
The Emerging Role of Medical Affairs in Biopharmaceutical Organizations: Challenges and Opportunities
Session Chair(s)
Honorio Silva, MD
President, International Federation of Associations of Pharmaceutical Physicians (IFAPP), United States
Medical affairs organizations within the pharmaceutical industry are emerging to provide patient and physician-centered services as part of a new business model aimed to provide value in health care. The challenges and opportunities for further growth will be analyzed.
Learning Objective : Analyze the most current obstacles in productivity of the pharmaceutical business including the expectations to bring added value services for patient-centered health care; Revise the contributions of the various medical affairs functions for an effective performance; Discuss challenges and required competencies in leveraging the reputation and credibility of the industry in the public opinion.
Speaker(s)
Panelist
Richard Murray, MD
Chief Medical Officer, Spire Health, United States
Panelist
Pol Vandenbroucke, MD, MBA, MS, FFPM
VP, Shionogi, United States
Panelist
Greg Koski, MD, PhD
President and CEO, Co-Founder, Alliance For Clinical Research Excellence and Safety (ACRES), United States
Have an account?
Ways to register
Registration override should work.